Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Peter Gimsing, Kristina Carlson, Ingemar Turesson, Peter Fayers, Anders Waage, Annette Vangsted, Anne Mylin, Christian Gluud, Gunnar Juliusson, Henrik Gregersen, Henrik Hjorth-Hansen, Ingerid Nesthus, Inger Marie S Dahl, Jan Westin, Johan Lanng Nielsen, Lene Meldgaard Knudsen, Lucia Ahlberg, Martin Hjorth, Niels Abildgaard, Niels Frost AndersenOlle Linder, Finn Wisløff

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

78 Citationer (Scopus)

Abstrakt

Udgivelsesdato: 2010-Oct
OriginalsprogEngelsk
TidsskriftThe Lancet Oncology
Vol/bind11
Sider (fra-til)973-82
Antal sider9
ISSN1470-2045
DOI
StatusUdgivet - 2010
Udgivet eksterntJa

Bibliografisk note

Copyright © 2010 Elsevier Ltd. All rights reserved.

Fingeraftryk Dyk ned i forskningsemnerne om 'Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater